Renalytix Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 16,384 | 0.0106% |
VC/PE Firms | 8,294,932 | 5.37% |
Hedge Funds | 8,705,196 | 5.64% |
Private Companies | 12,025,087 | 7.79% |
Individual Insiders | 15,491,101 | 10% |
General Public | 33,897,782 | 22% |
Institutions | 75,937,709 | 49.2% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
23,979,726 | US$3.3m | 24.4% | 2.96% | |||
13,866,061 | US$1.9m | 45.8% | 0.01% | |||
10,145,041 | US$1.4m | -5.86% | 0.14% | |||
10,072,500 | US$1.4m | 0% | no data | |||
8,705,196 | US$1.2m | 40.1% | 0.03% | |||
8,294,932 | US$1.2m | 0% | no data | |||
4,001,187 | US$556.5k | 0% | no data | |||
4,000,001 | US$556.3k | 0% | no data | |||
3,044,432 | US$423.4k | -20.2% | no data | |||
2,746,386 | US$382.0k | 1,330% | no data | |||
2,554,398 | US$355.3k | 0% | no data | |||
2,200,040 | US$306.0k | 0% | no data | |||
2,033,393 | US$282.8k | 0% | 0.01% | |||
2,022,619 | US$281.3k | -0.62% | no data | |||
1,805,236 | US$251.1k | 0% | no data | |||
1,415,484 | US$196.9k | -66.7% | 0.09% | |||
1,409,606 | US$196.0k | 381% | no data | |||
1,392,010 | US$193.6k | -17.8% | no data | |||
1,178,000 | US$163.8k | 0% | 0.02% | |||
1,050,232 | US$146.1k | 0% | 0.01% | |||
1,050,000 | US$146.0k | 0% | no data | |||
1,014,958 | US$141.2k | 0% | no data | |||
1,000,788 | US$139.2k | 25% | 0.04% | |||
905,771 | US$126.0k | 0% | no data | |||
897,800 | US$124.9k | 0% | 0.01% |